Risks for Anaphylaxis With Intravenous Iron Formulations
Ann Intern Med
.
2022 Nov;175(11):W143.
doi: 10.7326/L22-0282.
Authors
Hanny Al-Samkari
1
,
John A Glaspy
2
,
Robert T Means Jr
3
,
Glenn M Chertow
4
,
Michael Auerbach
5
Affiliations
1
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
2
University of California, Los Angeles, Los Angeles, California.
3
East Tennessee State University, Johnson City, Tennessee.
4
Stanford University School of Medicine, Palo Alto, California.
5
Georgetown School of Medicine, Washington, DC.
PMID:
36375165
DOI:
10.7326/L22-0282
No abstract available
Publication types
Comment
MeSH terms
Anaphylaxis* / chemically induced
Drug Hypersensitivity*
Humans
Iron / adverse effects
Substances
Iron